Erika Shor

When you're in Berlin, post #Candida2025, sightseeing and waiting at a random tram stop in city center, then randomly look up and see...

Ah, the day of impossible choices, aka parallel sessions. 🥺 #Candida2025

The first 24 hours of #Candida2025 have been fantastic. Really appreciate the breadth of focus of the talks and posters encompassing multiple Candida pathogens, not just C. albicans.

The preprint for our super fun collaboration with Erika Shor @mutant-fungus.bsky.social is out. Check it out to see some really beautiful PFGE karyotyping gels from Candida glabrata!

Is this thing still on?

Anyway, we have a new preprint out of a story that's been brewing in my lab for several years and is finally ready to see the light of day. It's about what happens to Candida glabrata while it's hanging out inside macrophages.

Today I learned that, apparently, one way to recognize writing created by AI is to look for em dashes, because AI uses them way more than humans do. This is a problem because this human loves em dashes -- they convey connections between sentence parts like no other punctuation symbol can.

A lovely summary of our recent AAC article featured on the website of Theobald Smith Society (New Jersey branch of the American Society for Microbiology).

Congratulations!

Expression of 1,3-β-glucan synthase subunits in Candida glabrata is regulated by the cell cycle and growth conditions and at both transcriptional and post-transcriptional levels | Antimicrobial Agents... β-1,3-glucan synthase (GS) is a fungal enzyme essential for cell wall biosynthesis and the target of echinocandins, a frontline antifungal drug class. Given the increasing resistance to azole-class dr...

If you're interested in beta-glucan synthase, the target of the echinocandins, check out our new paper, where we describe some cool new aspects of its expression and regulation in Candida glabrata.

journals.asm.org/doi/10.1128/...

Happening this morning: A key hearing in the cases challenging the NIH grant terminations.

Plaintiffs, including multiple state AGs + researchers, are requesting an injunction to reverse the terminations.

Our reporting has tracked what's at stake: projects.propublica.org/nih-cuts-res...

I've gotten Novavax in both 2023 and 2024 because it didn't give me any side effects (chills, weakness, muscle pains, etc.), unlike the mRNA vaccines. And now I'm not eligible for it. 😕🙄

Speaking to friends, I've likened the situation facing US researchers to that of the dinosaurs. We've competed for limited resources. We've adapted to our environment. We've evolved to be successful in the complex and competitive research ecosphere. And then a giant asteroid fell out of the sky.

Happy 80th anniversary of Hitler killing himself in his bunker to all who celebrate, which, as I now understand it, is not everybody

Tolerance and heteroresistance to echinocandins in Candida auris: conceptual issues, clinical implications, and outstanding questions | mSphere When Candida auris emerged as a new fungal pathogen over 15 years ago, it posed challenges similar to infections by other Candida species while exhibiting additional unique characteristics that rapidl...

Our short commentary on #echinocandin tolerance and heteroresistance in #Candidaauris.

What is happening to all that money? It's been allocated to the NIH by Congress, no? Is it sitting somewhere untouched or is it being misappropriated?

Thousands showed up for the #HandsOff rally in Princeton, NJ.

Will this make any difference? Is anyone listening?

Abbott Elementary is my ultimate comfort show

New constitutional crisis, who dis?

Columbia is a test run to see what they can get away with, using federal grants as a tool for political retribution. It’s happening, and there’s a good chance that any other university is next.

There’s a big courtroom showdown over NIH’s ‘indirect costs’ this week. What are they? Here’s the story behind the billions in payments to institutions with research grants that NIH wants to cut

Will NIH indirect costs survive in court this week?
Great article on what's at play.
www.science.org/content/arti...

This LinkedIn bot does not know that getting an R01 is the true pinnacle of success.

Excited to announce a save the date for the upcoming Keystone Fungal Pathogenesis meeting! Jan 12-15 2026, mark your calendars! 🗓 Program and deadlines in link below
#microsky #immunosky #KSFungalPath26 🧪
www.keystonesymposia.org/conferences/...

Welcome to the Bluesky account for Stand Up for Science 2025!

Keep an eye on this space for updates, event information, and ways to get involved. We can't wait to see everyone #standupforscience2025 on March 7th, both in DC and locations nationwide!

#scienceforall #sciencenotsilence

Here is the pre-RFK vaccination schedule for your kids. Please download it before he is confirmed and changes/deletes it.

Give it to your pediatrician and say this is the schedule you want your kids on.

Making this my pinned post.

YouTube video by Association of American Universities Facilities and Administrative (F&A) Costs Explainer

Make sure you, your trainees, and anyone else who might listen to you understands what "indirects" actually are, how they are established, and what Universities contribute. H/T @rodallab.bsky.social

Please share widely!

www.youtube.com/watch?v=yxTD...

Get in Dorks, we are going protesting.

STAND UP FOR SCIENCE. MARCH 7th 12-4pm. DC AND YOUR STATE CAPITALS.

More information to come.

Attention Attention Attention

If anyone knows clinicians or patients who have knowledge of pediatric patients with the very rare cancer interdigitating dendritic cell sarcoma (IDCS) or other (non-LCH) dendritic or histiocytoc sarcomas please contact Sri

The justification here is gibberish. Philanthropic orgs don’t set their F&A rate independent of NIH. They gauge their rate based on NIH’s rate to stretch their far more limited dollars to support more research. Lowering NIH’s rate throws this balance into chaos.

grants.nih.gov/grants/guide...

Universities will have to raise tuition and/or cut financial aid to offset these losses. Who will suffer? Basically, everyone.